ISU Abxis Co., Ltd. (KOSDAQ:086890)
5,970.00
-70.00 (-1.16%)
At close: Jan 29, 2026
ISU Abxis Market Cap
ISU Abxis has a market cap or net worth of 242.11 billion as of January 29, 2026. Its market cap has increased by 52.23% in one year.
Market Cap
242.11B
Enterprise Value
239.65B
Revenue
66.39B
Ranking
n/a
PE Ratio
9.37
Stock Price
5,970.00
Market Cap Chart
Since February 3, 2009, ISU Abxis's market cap has increased from 55.97B to 242.11B, an increase of 332.60%. That is a compound annual growth rate of 9.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 242.11B | 17.69% |
| Dec 30, 2025 | 205.73B | 28.77% |
| Dec 30, 2024 | 159.77B | -23.70% |
| Dec 28, 2023 | 209.40B | 9.75% |
| Dec 29, 2022 | 190.80B | -34.58% |
| Dec 30, 2021 | 291.68B | 43.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABION | 329.32B |
| Genome & Company | 321.19B |
| Vaxcell-Bio Therapeutics | 255.37B |
| Prestige Biologics | 233.26B |
| Kangstem Biotech | 202.22B |
| Bio Solution | 192.90B |
| Ensol Biosciences | 187.72B |
| curacle co.,ltd. | 186.77B |